| Literature DB >> 35008871 |
Ying-Xia Jiang1,2,3,4,5, Jin-Zhi Chen1,2,3,4,5, Miao-Wen Li1,2,3,4,5, Ben-Hu Zha1,2,3,4,5, Peng-Rong Huang1,2,3,4,5, Xue-Mei Chu1,2,3,4,5, Jing Chen1,2,3,4,5, Guang Yang1,2,3,4,5.
Abstract
RNA interference (RNAi) has been developed and used as an emerging strategy for pest management. Here, an entomopathogen Bacillus thuringiensis (Bt) was used to express the dsRNA for the control of Plutella xylostella. A vector containing a 325-bp fragment of the conserved region of P. xylostella arginine kinase gene (PxAK) flanking in two ends with the promoter Pro3α was developed and transferred into Bt 8010 and BMB171, and consequently engineered Bt strains 8010AKi and BMB171AKi expressing dsRNA of PxAK were developed. The two engineered Bt strains were separately mixed with Bt 8010 in a series of ratios, and then fed to the P. xylostella larvae. We found that 8010:8010AKi of 9:1 and 8010:BMB171AKi of 7:3 caused a higher mortality than Bt 8010. PxAK expression levels in the individuals treated with the mixtures, 8010AKi and BMB171Aki, were lower than that in the control. The intrinsic rate of increase (r) and net reproductive rate (R0) of the population treated with 8010:8010AKi of 9:1 were lower than those of the population treated with Bt 8010 or 8010AKi. We developed a Bt-mediated insect RNAi for the control of P. xylostella and demonstrated a practical approach to integrating the entomopathogen with RNAi technique for the pest management.Entities:
Keywords: Plutella xylostella; RNA interference; entomopathogen; pest management
Mesh:
Substances:
Year: 2021 PMID: 35008871 PMCID: PMC8745139 DOI: 10.3390/ijms23010444
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Construction of a recombinant Bt expressing dsRNA of PxAK. (a) The schematic representation of PxAK and the AKi fragment used in the experiment. The white box stands for the motif CPTNLGT. (b) A recombinant Bt pHT305AK2 plasmid containing the expression cassette for dsRNA of AKi; Pro3α(−) on the left of AKi; Pro3α(+) on the right of AKi. (c) Verification of engineered Bt strains by PCR to check the presence of vector pHT305AK2 and Cry gene. The PCR product for vector and Cry gene were 396 bp and 238 bp, respectively. (d) Detection of small RNA in engineered Bt strains by 19% PAGE-Urea gel. (e) Detection of the expression of AKi in engineered Bt strains.
Figure 2Insecticidal activity of engineered Bt strains against P. xylostella. (a) Oral toxicity of bacteria against P. xylostella. Each group contained 30 4th-instar larvae and mortality was measured every 12 h. (b) Effect of bacteria on P. xylostella development. In 1, the right antenna was shorter than the left; in 2, and 8, body appeared to exhibit shrinkage; in 3 and 9, the whole body turned blackish or green and the thorax appeared to exhibit shrinkage; in 4, thorax appeared to exhibit extreme shrinkage; in 5, the adult failed to break the cocoon; in 10, the pupa failed to ecdysis; in 6 and 7, the body turned black and erosive; in 11, the body was elongated; in 12, no abnormal phenotype was observed.
Figure 3Mortality of P. xylostella caused by the mixtures of Bt 8010 and engineered Bt expressing dsRNA of PxAK. The mortality of P. xylostella caused by the bacteria mixtures in different ratios were collected every 24 h and three biological replications were performed for each treatment. (a) Bt 8010:8010AKi; (b) Bt 8010:BMB171AKi. The total number of dead P. xylostella caused by the mixtures of Bt 8010 and engineered Bt in different ratios were recorded and three biological replications were performed for each treatment. (c) Pupae; (d) Larvae. The bars represent the mean ± SE of each treatment. Different lowercase letters represent significant differences among the mixtures of different ratios for 8010:8010AKi and 8010:BMB171AKi separately by Tukey test in one-way ANOVA (p < 0.05).
Figure 4Effects of the mixtures of 8010 and engineered Bt on P. xylostella pupal weight and PxAK expression. The pupal weight of P. xylostella treated with the bacteria mixtures of different ratios. (a) 8010:8010AKi; (b) 8010:BMB171AKi. Values represent the mean ± SE of pupal weight of P. xylostella from three biologically independent replicates of each treatment at each time point. (c) PxAK expression in P. xylostella treated with 8010:8010AKi or 8010:BMB171AKi of different ratios. PxRPL8 was used as the reference gene, and the PxAK expression in P. xylostella treated with H2O was the control. The bars represent the mean ± SE of relative expression of PxAK mRNA transcripts from three biologically independent replicates of each treatment. The different lowercase letters represent significant differences among the mixtures of different ratios at each time point by Tukey test in one-way ANOVA (p < 0.05).
Population dynamics parameters of P. xylostella in different treatments (Mean ± SE).
| Treatment | Intrinsic Rate of Increase, | Finite Rate of Increase, | Net Reproductive Rate, | Mean Generation Time, |
|---|---|---|---|---|
| H2O | 0.2427 ± 0.0090 ab | 1.2746 ± 0.0115 ab | 70.4682 ± 10.1416 ab | 17.5360 ± 0.1570 b |
| 8010 | 0.2529 ± 0.0107 a | 1.2878 ± 0.0137 a | 69.7647 ± 10.9253 ab | 16.7840 ± 0.2340 c |
| 8010AKi | 0.2510 ± 0.0089 a | 1.2852 ± 0.0114 a | 81.9904 ± 11.3744 a | 17.5590 ± 0.2170 b |
| 8010:8010AKi of 1:9 | 0.2065 ± 0.0115 c | 1.2293 ± 0.0141 c | 45.9127 ± 8.9724 bc | 18.5360 ± 0.2660 a |
| 8010:8010AKi of 3:7 | 0.2153 ± 0.0117 bc | 1.2403 ± 0.0145 bc | 52.2844 ± 10.1531 abc | 18.3760 ± 0.2280 a |
| 8010:8010AKi of 5:5 | 0.2383 ± 0.0115 abc | 1.2691 ± 0.0146 abc | 66.1250 ± 12.3838 abc | 17.5920 ± 0.2250 b |
| 8010:8010AKi of 7:3 | 0.2145 ± 0.0099 c | 1.2393 ± 0.0122 c | 56.4240 ± 9.3667 abc | 18.7990 ± 0.2530 a |
| 8010:8010AKi of 9:1 | 0.2097 ± 0.0147 c | 1.2333 ± 0.0180 c | 39.8571 ± 9.3817 c | 17.5760 ± 0.2460 b |
Different letters following mean ± SE in the same row represent significant differences among species based on the paired bootstrap test (200,000 bootstraps, p < 0.05).